Market Value333,168,000
Total Holdings91
File Date2014-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ABMD / Abiomed Inc.
ACAD / ACADIA Pharmaceuticals Inc.
AEGR / Aegerion Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
018490100 / Allergan plc
ANTH / Anthera Pharmaceuticals, Inc.
ARIA / ARIAD Pharmaceuticals, Inc.
/ Array BioPharma, Inc.
AUXL / Auxilium Pharmaceuticals Inc
BIND / BIND Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
NKTR / Nektar Therapeutics
BAX / Baxter International Inc.
CFNL / Cardinal Financial Corp.
CFN / CareFusion Corporation
CTRX /
CELG / Celgene Corp.
CLDX / Celldex Therapeutics, Inc.
CPHD / Cepheid
CYH / Community Health Systems, Inc.
CYBX / Cyberonics, Inc.
PFE / Pfizer Inc.
EW / Edwards Lifesciences Corporation
US29266S3040 / Endologix, Inc.
ECYT / Endocyte, Inc.
Actavis Plc / SHS (30083B108)
EXEL / Exelixis, Inc.
ESRX / Express Scripts Holding Co.
AMGN / Amgen Inc.
345838106 / Forest Laboratories Inc
HAE / Haemonetics Corporation
TMO / Thermo Fisher Scientific Inc.
BMY / Bristol-Myers Squibb Company
MCK / McKesson Corporation
HPTX / Hyperion Therapeutics Inc
IMGN / ImmunoGen, Inc.
INCY / Incyte Corporation
INFI / Infinity Pharmaceuticals Inc.
JNJ / Johnson & Johnson Call
JNJ / Johnson & Johnson
KERX / Keryx Biopharmaceuticals, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
LGND / Ligand Pharmaceuticals Incorporated
MGNX / MacroGenics, Inc.
MASI / Masimo Corporation
MDVN / Medivation, Inc.
MYGN / Myriad Genetics, Inc.
NPSP / NPS Pharmaceuticals Inc
BMRN / BioMarin Pharmaceutical Inc.
LUMO / Lumos Pharma, Inc.
NUVA / Nuvasive Inc
OCR /
OREX / Orexigen Therapeutics, Inc.
PRXL / PAREXEL International Corp.
PCYC / Pharmacyclics
RAD / Rite Aid Corp.
STJ / St. Jude Medical, Inc.
SLXP / Salix Therapeuticals, Inc.
SRNE / Sorrento Therapeutics, Inc.
VIRX / Viracta Therapeutics, Inc.
SUPN / Supernus Pharmaceuticals, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
885175307 / Thoratec
MTEM / Molecular Templates, Inc.
TROV / TrovaGene, Inc.
US92220P1057 / Varian Medical Systems, Inc.
VOLC / Volcano Corp
ELV / Elevance Health, Inc.
COV /
UNH / UnitedHealth Group Incorporated
RVNC / Revance Therapeutics, Inc.
CVS / CVS Health Corporation
SYK / Stryker Corporation
MRK / Merck & Co., Inc.
ALKS / Alkermes plc
ABBV / AbbVie Inc.
GILD / Gilead Sciences, Inc.
HCA / HCA Healthcare, Inc.
LLY / Eli Lilly and Company
REGN / Regeneron Pharmaceuticals, Inc.
DVAX / Dynavax Technologies Corporation
DXCM / DexCom, Inc.
UHS / Universal Health Services, Inc.
CNC / Centene Corporation
MDT / Medtronic plc
CI / The Cigna Group
BIIB / Biogen Inc.
BDX / Becton, Dickinson and Company
COR / Cencora, Inc.
PODD / Insulet Corporation
BSX / Boston Scientific Corporation